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Summary 
Thymocytes must bind major histocompatibility complex (MHC) proteins on thymic epithelial 
cells in order to mature into either CD8 + cytotoxic T cells or CD4 + helper T cells. Thymic 
precursors express both CD8 and CD4, and it has been suggested that the intracellular signals 
generated by CD8 or CD4 binding to class I or II MHC,  respectively, might influence the fate 
of  uncommitted cells. Here we test the notion that intracellular signaling by CD4 directs the 
development of  thymocytes to a CD4 lineage. A hybrid protein consisting of  the CD8 extra- 
cellular and transmembrane domains and the cytoplasmic domain of  CD4 (CD884) should 
bind class I MHC but deliver a CD4 intracellular signal. We find that expression of  a hybrid 
CD884 protein in thymocytes oftransgenic mice leads to the development of  large numbers of  
class I MHC-specific, CD4 lineage T cells. We discuss these results in terms of  current models 
for CD4 and CD8 lineage commitment. 
T he differentiation of  immature thymocytes into either CD4 § or CD8 + mature T cells is linked to the speci- 
ficity of  the TCRs  expressed on developing thymocytes. 
Recognition of  class I MHC by developing thymocytes re- 
quires the coordinate binding of  both a class I-specific 
TCR and a CD8 coreceptor, and can give rise to mature 
CD8 + T cells. In contrast, recognition of  class II MHC re- 
quires corecognition by a class II-specific TCR and the CD4 
coreceptor and can give rise to mature CD4 + T cells. Al- 
though immature thymocytes express both CD4 and CD8, 
as thymocytes mature, they downregulate expression of  one 
of the coreceptors, giving rise to mature CD4+CD8 - or 
CD4-CD8 § T cells. Thus lineage commitment in the thy- 
mus is linked to both the specificity of  the TCR and the 
expression of  the CD4 and CD8 coreceptors. 
The observation that the specificity of  TCR for class I or 
II MHC influences the choice between CD4 and CD8 lin- 
eages is consistent with a model in which binding of  class I 
MHC by a CD4+CD8 + thymocyte l ads to the downregu- 
lation of  CD4 expression and commitment to a CD8 fin- 
eage. Likewise, binding of  class II MHC may lead to the 
downregulation of  CD8 expression and commitment to a 
CD4 lineage (1). This model fits well with observations 
from TCR transgenic mice, in which expression of  a class 
I-specific TCR generally leads to an increase in the pro- 
duction of  mature CD8 cells, and expression of  a class I I -  
specific TCR generally leads to an increase in the produc- 
tion of  mature CD4 cells (2-5). 
The analysis of  putative transitional intermediates in MHC-  
deficient mice has been interpreted as evidence against an in- 
structive model. For example, apopulation of CD4+CD8 l~ 
thymocytes i observed in mice mutant for class II MHC,  
but is missing in mice mutant for both class I and II MHC 
(6, 7). It has been proposed (7) that this population repre- 
sents class I-selected transitional cells that are committed to 
a CD4 lineage, a population that would not be predicted by 
an instructive model. There is, however, no direct evidence 
that the CD4+CD8 l~ cells are the precursors of  CD4 lineage 
cells. Indeed, recent experiments indicate that at least some 
CD4+CD8 ]~ thymocytes give rise to CD8 lineage cells 
(8), raising questions about the implications of  this population 
for the mechanism of CD4/CD8 lineage commitment. 
Another line of  evidence that lineage commitment need 
not correlate with MHC specificity comes from mice ex- 
pressing constitutive CD8 or CD4 transgenes (9-15). Al- 
though these experiments provide evidence for a stochastic 
component to lineage commitment, it is striking that the 
generation of  T cells of  the "wrong" lineage (i.e., CD4 § 
with class I-specific TCRs  or CD8 + with class II-specific 
TCRs) is invariably inefficient. For example, class II MHC 
mutant, CD8 transgenic mice have only ~3% of the ma- 
ture CD4 § thymocytes that are found in mice that are wild 
type for class II MHC (10). Moreover, another class I-spe- 
cific TCR,  anti-HY, failed to give rise to any detectable 
CD4 lineage cells when coexpressed with a CD8 transgene 
(16-18), implying that not all class I-specific TCRs  can 
permit the development of  CD4 lineage cells. 
In light of  these considerations, we decided to examine 
more directly the question of  whether intracellular signals 
generated upon MHC recognition might influence the fate 
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of  uncommitted thymocytes. Here we directly test the hy- 
pothesis that CD4 intracellular signals promote the devel- 
opment of  CD4 lineage T cells. A hybrid molecule consist- 
ing of  the extracellular domain of  CD8 and the cytoplasmic 
domain of  CD4 would be expected to bind class I MHC,  
yet deliver a CD4 intracellular signal. If  CD4 signals direct 
thymic precursors to choose~the CD4 lineage, then the rec- 
ognition of  class II MHC by thymocytes expressing such a 
hybrid molecule would direct development to a CD4 in- 
stead of  a CD8 lineage. Indeed, we find that coexpression 
of  a hybrid CD8/4  molecule with the F5 TCR leads to a 
dramatic increase in mature CD4 cells, and a decrease in 
mature CD8 cells. These results indicate that the cytoplas- 
mic domain of  CD4 delivers a signal that favors the devel- 
opment of  CD4 lineage cells. 
Materials and Methods 
Generation of Transgenic Mice Expressing CD884 Hybrid Moleo 
cules. A Nael site was introduced into the CD8.1 cDNA (16) at 
amino acid 196 by site-directed mutagenesis. The sequence of the 
mutagenic oligonucleotide was 5'-aac acg ctg ccg gct cct gtg-3'. 
This Nael site was ligated to the existing Nael site at amino acid 
400 of the murine CD4 gene. The resulting hybrid cDNA en- 
codes a fusion protein whose extracellular nd transmembrane 
domains derive from the CD8 gene (through amino acid Ser 195 
[19]), and whose cytoplasmic domain derives from CD4 (from 
amino acid Arg 400 [20]). The hybrid cDNA was inserted into 
the EcoR.I site of the human CD2 expression cassette, to produce 
a transgenic construct that is analogous to the "T l l -8"  construct 
that was used to generate CD8.1 transgenic mice (16). This con- 
struct was coinjected along with a CD813.1 genomic lone (21) into 
C57B1/10 embryos. One founder which expresses transgenic 
CD8.~xl and CD813.1 at levels comparable to the endogenous 
CD8 genes was chosen for further analysis. Hematopoietic stem cell 
chimeras were generated by injecting mixtures ofT cell-depleted 
bone marrow cells from F5 TCR and F5 TCR/CD884 trans- 
genic mice (2 • 107 cell/recipient) into unirradiated P,.agl mu- 
tant mice (22). 
Analysis of Lck Association. Thymocytes (107 cells/sample) were 
lysed in 1 ml oflysis buffer (50 mM Tris, pH 7.5, 0.1% NP-40, 
1 mM Na3VO4, 10 mM NaF, 10 mM Na4P207, 1 mM PMSF, 
10 l~g/ml aprotinin, and 10 p~g/ml leupeptin). Lysates were cen- 
trifuged for 1 min at 14,000 rpm and the supematants were incu- 
bated with 25 Ixl protein G beads (GammaBind G Sepharose; 
Pharmacia, Piscataway, NJ) that had been precoated with either 
anti-CD4 (GK1.5) or anti-CD8 (53-6.72). After 3 h at 4~ beads 
were washed twice with lysis buffer without detergent. Nonreduc- 
ing SDS loading buffer was added to the samples, which were 
heated for 5 min at 95~ Samples were run on an SDS polyacryl- 
amide gel and transferred to nitrocellulose (Hybond-ECL; Amer- 
sham Corp., Arlington Heights, IL). Irnmunoblotting was per- 
formed using the enhanced chemiluminescence system (ECL; 
Amersham Corp.) according to the manufacturer's instructions. 
Anti-Lck antibody was kindly provided by Dr. Joe Bolen (Bris- 
tol-Myers Squibb, Princeton, NJ) and was visualized using horse- 
radish peroxidase goat anti-mouse Ig (Southern Biotechnology 
Associates, Birmingham, AL). 
Analysis of Lck Activation. CD8 and CD884 constructs were 
cloned into a SV40 expression cassette (23) and introduced by 
electroporation into Jurkat cells along with a selectable plasmid. 
Individual hygromycin B resistant clones expressing comparable 
cell surface levels of CD8 were selected for cross-linking experi- 
ments. Cross-linking was performed as follows. 107 cells were in- 
cubated with 20 Ixg rat anti-murine CD8 IgG (clone 53-6.72) for 
15 min on ice, then with 60 Ixg goat anti-rat IgG (Cappel Labo- 
ratories, Durham, NC) for 15 rain on ice. Cells were then incu- 
bated for 10 min at 37~ rinsed with cold PBS containing 1mM 
Na3VO 4 and 10 mM NaF, and lysed for 20 min in lysis buffer on 
ice. Lysates were cleared by centrifugation for 10 min at 10,000 g 
and incubated with 25 Ixl protein G beads for 6 h at 4~ Beads 
were then washed four times with lysis buffer (without Na4P207 
and PMSF), once with kinase buffer (50 mM Hepes, pH 7.5, 100 
mM NaC1, 5 mM MgC12, and 5 mM MnC12) , and resuspended in 
30 Ixl kinase buffer containing 10 I~Ci ~/-[32p]ATP and 10 Ixg 
acid-denatured nolase (Sigma Chemical Co., St. Louis, MO). 
Reactions were run for 10 min at 30~ quenched with 15 I~1 3• 
sample buffer (150 mM Tris, pH 6.8, 30% glycerol, 6% SDS, 3% 
2-ME and 0.05% bromophenol b ue), and reaction products were 
analyzed by SDS-PAGE. The gel was then fixed and dried for au- 
toradiography. Quantification ofradioactive bands was performed 
using the Phosphorlmager/ImageQuant system (Molecular Dy- 
namics, Sunnyvale, CA). For the in vitro kinase assay on thy- 
mocytes, immunoprecipitations were performed as described above 
for the Western blot. Immunoprecipitates were resuspended in
kinase buffer and assays were performed as described above. 
Analysis of T Cell Populations. Class II MHC mutant, anti-HY 
and F5 TCR transgenic mice have been previously described (3, 
24, 25). All mice were homozygous for H-2 b. Cell suspensions of
thymocytes and lymph node T cells were prepared and labeled 
with fluorescent antibodies as previously described (11). For anal- 
ysis of mature thymocytes, thymocytes were treated with anti- 
heat stable antigen (HSA) 1 and complement as previously de- 
scribed (10). Antibodies used were T3.70 (culture supematant), 
PE-labeled goat anti-mouse IgG1 (Caltag Laboratories, South 
San Francisco, CA), PE-labeled CD4 (Beckton Dickinson & Co., 
Mountain View, CA), anti-CD8.2~ FITC (2.43), Tricolor xM- 
labeled streptavidin (Caltag), and rat gamma globulin (Calbiochem- 
Novabiochem Corp., San Diego, CA), anti-CD8.1 (49-31.1; 
Cedarlane Laboratories, Westbury, NY), FITC-labeled goat anti- 
mouse IgG3 (Caltag), biotinylated anti-CD4 (YTS 191.1; Cal- 
tag), biotinylated anti-Vet2 (PharMingen, San Diego, CA), and 
biotinylated anti-VI311 (KT11). Data (50,000 events) were col- 
lected and analyzed using a FACScan | flow cytometer (Becton 
Dickinson & Co.) or X-cell flow cytometer (Coulter Corp., Hi- 
aleah, FL). Dead cells were excluded on the basis of forward and 
side scatter. 
Results 
Transgenic Mice Expressing a Hybrid CD8/CD4 Transgene. 
To redirect a CD4 intracellular signal, we constructed a hy- 
brid cDNA consisting of  the extracellular and transmem- 
brane domains of  CD8a and the cytoplasmic domain of CD4 
(CD884). The CD8o~ cDNA used encodes the CD8.1 al- 
lele, which can be distinguished from the endogenous CD8 
allele (CD8.2) using monoclonal antibodies. The hybrid 
cDNA (Fig. 1 a) was inserted into an expression cassette 
containing the human CD2 promoter, minigene, and 3' 
locus controlling region, to generate a construct analogous 
1Abbreviations used in this paper: HSA, heat stable antigen; NP, nucleopro- 
tein. 
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Figure 1. Redirecting a CD4 intraceUular signal with a hybrid CD8/CD4 coreceptor. (a) Construct used in the generation of CD884 transgenic mice. 
(White) Transmembrane domain. (Arrow) Direction of transcription; the sequence surrounding the fusion is depicted below. (Underlined) Nael site. The 
map is not drawn to scale. Restriction endonuclease ites: Sall (S), BamH1 (/3), and Xbal (X). The CD884 transgene was coinjected with a 15-kb 
BamH1 genonfic fragment encoding CD813.1 (21) into C57B1/10 embryos. (b) CD884 protein is more effective than CD8 in activating Lck. The 
CD884 and CD8 cDNAs were cloned into a SV40 expression vector and used to transfect the human T cell line Jurkat. Anti-CD8 immunoprecipitates 
from stable transfectants expressing comparable l vels ofmurine CD8 cell were analyzed using an in vitro kinase assay as described in Materials and Methods. 
Lck activity was quantitated by integrating signals of enolase bands. (Arrows) Migration positions of Lck and enolase. (Le~) Migration positions of molecular 
weight (kDa) standards. (c) CD8a expression on CD884 and CD8.1 transgenic (tg) mice. Thymocytes were stained with anti-CD8~t, which recognized 
both endogenous and transgenic CD8. (d) CD813.1 expression on CD884 and CD8.1 transgenic mice. Thymocytes were stained with anti-CD8[3.1, 
which recognizes transgenic, but not endogenous CD813. (e) Lck associated with CD4 and CD8 in thyrnocytes of CD884 and CD8.1 transgenic mice. 
Thymocytes from the indicated mice were subjected to immunoprecipitation with the indicated antibodies. Immunoprecipitates were resolved by PAGE 
and analyzed by Western blot analysis using anti-Lck antibodies. The experiment was performed twice with equivalent results. (jr) Active Lck associated 
with CD4 and CD8 in thymocytes of CD884 and CD8.1 transgenic mice. Thymocytes from the indicated mice were subjected to immunoprecipitation 
with the indicated antibodies, lmmunoprecipitates were then subjected to in vitro kinase assays as described in Materials and Methods. The experiment 
was performed twice with equivalent results. 
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Table 1. Thymocytes and Lymph Node T Cells fiom CD884 Transgenic Mice 
Percent otal thymocytes Percent HSA-Thymocytes 
No. of cells/thymus TCR. + TCR + 
Genotype X 10 6 CD4 + 8.2- CD4- 8.2 + CD4 + 8.2- CD4- 8.2 + 
% % 
Nontransgenic 225 (126) 7.1 (1.7) 2.4 (0.9) - - 5 
CD884 transgenic 171 (66) 10 (2.6) 2.3 (0.6) - - 8 
Class II- 230 (33) 1.3 (0.3) 2,9 (0.4) 2.4 (0.6) 68 (5.6) 3 
Class II-/CD884 transgenic 193 (61) 5.1 (0.6) 2,2 (0.2) 26 (7.5) 49 (3.3) 3 
Percent lymph node T cells 
CD4 + 8.2- CD4- 8.2 + 4:8 ratio n 
% 
Nontransgenic 56 (3,4) 38 (3.2) 1,5 9 
CD884 transgenic 63 (5.2) 24 (2.5) 2.6 8 
Class II- 3.4 (0.2) 88 (4.2) 0.04 3 
Class II-/CD884 transgenic 33 (2.2) 58 (1,6) 0.6 3 
Total thymocytes, mature thymocytes (HSA depleted), or lymph node T cells (B cell depleted) were stained with antibodies against TCR, CD4, and 
CD8.2 (endogenous CD8), as described inMaterials and Methods. CD884 transgenic mice were either heterozygous or homozygous for the CD884 
transgene. Average values are given with standard deviations inparentheses, and n is the number of mice analyzed of each genotype. 
to one previously used to direct constitutive xpression of  a 
wild-type CD8 cDNA (16, 26). 
To test whether the CD4 cytoplasmic domain is func- 
tional in the context of  the CD884 protein, we examined 
the ability of the CD884 molecule to activate the tyrosine 
kinase p56 lck (Lck). Although the cytoplasmic domains of  
both CD4 and CD8 interact with Lck, cross-linking of  CD4 
activates Lck more strongly than does cross-linking of  CD8 
(27-29). We introduced both the CD884 and the wild 
type-CD8 constructs into the human T cell line Jurkat, and 
isolated stable transfectants expressing comparable surface 
levels of either CD884 or wild-type CD8. Transfectants were 
then subjected to cross-linking using antimurine CD8 anti- 
bodies, and in vitro kinase assays were performed on anti- 
CD8 immunoprecipitates. We find that cross-linking of  
CD884 molecules leads to approximately eightfold higher 
activation of  Lck than does cross-linking of  wild-type CD8 
(Fig. 1 b). This indicates that the cytoplasmic domain of  
CD4, when fused to the extracellular and transmembrane 
domain of  CD8, activates Lck more strongly than does the 
cytoplasmic domain of  CD8. 
Although CD8ct can be expressed as a homodimer, it is 
generally found as a heterodimer paired with a [~ chain, and 
recent evidence indicates that the [~ chain of CD8 plays an 
important role in thymic development (30-32). To ensure 
that CD8[3 is not limiting, and to mimic more closely the 
original CD8 transgenic mice, we coinjected a genomic 
clone encoding CD813 (21) along with the CD884 trans- 
genic construct. A line that expresses CD884 and CDSJ3 on 
virtually all thymic and peripheral T cells at levels compara- 
ble to endogenous CD8 was chosen for further analysis. The 
cell surface expression of  CD8~x on thymocytes of  CD884 
transgenic mice is comparable to endogenous CD8 expres- 
sion and is very similar to the levels on previously described 
CD8.1 transgenic mice (Fig. 1 c). Both CD884 and CD8.1 
transgenic mice also express comparable surface levels of  
CD813.1 (Fig. 1 d). 
Because the cytoplasmic domain of CD4 associates strongly 
with Lck, we suspected that thymocytes from CD884 trans- 
genic mice would have more CD8-associated Lck than thy- 
mocytes from nontransgenic or CD8.1 transgenic mice. To 
investigate this question, we prepared anti-CD8 and anti- 
CD4 immunoprecipitates from thymocytes ofnontransgenic, 
CD884 transgenic, and CD8.1 transgenic mice, and per- 
formed both in vitro kinase assays and anti-Lck. Western 
blot analysis (Fig. 1, e and f). As expected, we found an in- 
crease in both Lck immunoreactivity (Fig. 1 e) and kinase 
activity (Fig. 1 f )  in anti-CD8 immunoprecipitates from 
CD884 transgenic mice relative to nontransgenic or CD8 
transgenic mice. It is also interesting to note that anti-CD8 
immunoprecipitates from thymocytes o fCD8 transgenic mice 
have an increased association with Lck relative to nontrans- 
genic mice. This may reflect the fact that the level of CD8 
expression in thymocytes of  CD8 transgenic mice is slightly 
elevated relative to nontransgenic, and/or the fact that the 
CD8 transgene does not encode CD8od, an alternative 
splice version of  CD8 that cannot associate with Lck (33). 
Class 1-specific, CD4 Lineage T Cells Develop in CD884 
Transgenic Mice. In our initial analysis o fCD884 transgenic 
mice, we examined thymocytes and lymph node T cells for 
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Tota l  Thymus  
F5 TCR tg F5 TCR/ 
CD8.1 tg 
8 
12.3_~ r '~t4! 
Z 
CD8.2 
F5 TCR 
F5 TCR/ 
CD884 tg 
CD8.1 
Figure 2. Thymic subsets in mice coexpressing the F5 TCR and the 
CD884 transgenes. Expression of CD4 and CD8.2 (endogenous CD8) 
(a-c), V1311 (d-f), or CD8.1 (transgenic CDS) (g--t) in thymocytes from 
F5 TCR (a, d, andg), F5 TCIq./CD8.1 (b, e, and h) or F5 TCR/CD884 
(c, f, and t) transgenic mice. Thymocytes were analyzed with fluorescent 
antibodies a  described inMaterials and Methods. The numbers inside the 
quadrants represent the percentage of cells in each population. 
expression of  TCR., CD4, and endogenous CD8 (CD8.2) 
by flow cytometry (Table 1). It is interesting to note that 
we observed a slight increase in the ratio o f  mature CD4 to 
CD8 T cells in the lymph node and thymus of  CD884 
transgenic mice. This increase in the ratio of  CD4 to CD8 
cells is consistent with the possibility that both class I -  and 
II-specific T cells are present in the mature CD4 popula- 
tion in CD884 transgenic mice. 
If mature CD4 + T cells in CD884 transgenic mice are 
selected on class I MHC,  they should not be dependent on 
class II MHC for their development. To examine this 
question, we backcrossed the CD884 transgene to mice 
that are deficient for class II MHC because of  a targeted 
disruption of  the I -A 13 gene (24). Whereas class II MHC 
mutant mice have very few peripheral CD4 cells (24, 34), 
the ratio of  peripheral CD4 to CD8 cells in CD884 trans- 
genic, class II mutant mice is 0.6, compared to 1.5 in mice 
that are wild type for class II MHC (Table 1). 
There is also a substantial population of  mature CD4 
cells (TCRhig~CD4+CD8.2 -) in the thymus ofCD884 trans- 
genic, class II mutant mice (Table 1). To more accurately 
determine the ratio of  mature CD4 to CD8 thymocytes, 
we depleted thymocytes of  immature cells by treating them 
with anti-HSA and complement. The resulting mature thy- 
mic population was then analyzed for expression of  TCR., 
CD4, and CD8.2. When analyzed in this manner, non- 
transgenic mice have a ratio of  mature CD4 to CD8 cells of  
approximately 2, whereas class I I -deficient mice show a ra- 
tio of  <0.05 [10]. In contrast, expression of  the CD884 
transgene in a class II mutant background results in a thy- 
mic CD4 to CD8 ratio of  0.5. As previously shown, ex- 
pression of  a wild-type CD8 transgene in class II MHC 
mutant mice also restores the development of  some mature 
CD4 thymocytes, however the CD4 to CD8 ratio is only 
0.08 in CD8 transgenic, lass II mutant mice (10). This is in 
spite of  the fact that the surface expression o f  the wild-type 
CD8 transgene is slightly higher than the CD884 transgene 
(Fig. 1 c and Fig. 2, h and i). Thus the CD884 molecule is 
much more efficient han wild-type CD8 at permitting the 
development of  class I-selected CD4 lineage T cells. 
The Effect of the CD884 Transgene on Selection of the F5 
TCR. We also examined the effect of  the CD884 trans- 
gene expression on the selection of  two individual class 1-spe- 
cific TCRs,  F5 and anti-HY. The F5 TCR recognizes a
nucleoprotein peptide bound to the class I MHC protein, 
H-2D b, and mice expressing an F5 TCR transgene have 
greatly increased numbers of  mature CD8 thymocytes and 
very few mature CD4 thymocytes (25; Table 2 and Fig. 2 
a). It is striking that in mice expressing both the F5 TCR 
Table 2. Thymocytes and Lymph Node T Cells fiom Mice Coexpressing the F5 TCR and CD884 Transgenes 
Percent otal thymocytes 
No. of ceUs/thymus 
Genotype • 106 CD4 + 8.2- CD4- 8.2 + 4:8 ratio n 
F5 TCR transgenic 198 (97) 2.4 (0.9) 15 (4.6) 0.2 6 
F5 TCR/cd884 transgenic 114 (20) 50 (8.9) 7.4 (1.6) 6.8 6 
Percent lymph node T cells 
CD4 + 8.2- CD4- 8.2 + 4:8 ratio n 
F5 TCR transgenic 
F5 TCR/CD884 transgenic 
7.6 (1.2) 87 (1.7) 0.1 6 
56 (15) 32 (11) 1.8 8 
Thymocytes or lymph node T cells (B cell-depleted lymph node cells) were stained with antibodies against CD4 and CD8.2 (endogenous CDS) as 
described in Materials and Methods. Representative data are shown in Figs. 2 and 3. Average values are given with standard eviations in parenthe- 
ses, and n is number of mice of each genotype analyzed. 
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and the CD884 transgenes, this pattern is reversed (Fig. 2 c 
and Table 2). In the thymus ofF5 TCR/CD884 transgenic 
mice, the mature CD4 subset represents "~50% of thy- 
mocytes and the mature CD8 subset is reduced approxi- 
mately twofold compared to F5 TCR transgenic mice. Ex- 
pression of  a wild-type CD8 transgene also leads to an 
increased number of  mature CD4 cells (11, and Fig. 2 b); 
however, this effect is much less dramatic than that ob- 
served with the CD884 transgene, in spite of  the higher 
level of  expression of  the CD8 transgene (Fig. 1, c and d 
and Fig. 2, h and 0- Moreover, in F5 TCR/CD884 trans- 
genic mice, the increase in the CD4 subset is accompanied 
by a decrease in the mature CD8 subset. 
A similar trend is observed in the lymph node of F5 
TCR/CD884 transgenic mice (Fig. 3 and Table 2). The 
average ratio of  CD4 to CD8 cells is 1.8 in F5 TCR/CD884 
transgenic mice, compared to 0.1 in F5 TCR and 0.3 in F5 
TCR/CD8.1  transgenic mice (11). The majority of  the 
CD4 cells in the lymph node of F5 TCR/CD884 trans- 
genic mice also express V~I 1 (Fig. 3f) ,  consistent with the 
notion that they express the F5 TCR.  Because some rear- 
rangements of  the endogenous TCR genes can occur in 
TCR transgenic mice, however, it is important o confirm 
that the CD4 + T cells express the F5 TCR rather than en- 
dogenous TCRs. Because there is no anticlonotypic antibody 
F5 TCR/ F5TCR/ 
F5TCRtg CD8.1tg CD884tg 
7 . '5~ 70 
CD8.2 
~ d  I ~68 I~  el 116 __[r f] 
CD4 
eq 
CD8.2 > 
lj 1(13fo)lk , ~9.6~/o~ :11 ~2.3~ 
CD4 
Figure 3. Lymph node T cells in mice coexpressing the F5 TCR and 
the CD884 transgenes. Expression of CD4, CD8.2 (endogenous CD8), 
V[B11 (transgenic TCR[3), and Vct2 (endogenous V~x) in lymph node T 
cells from F5 TCR (a, d,g, and/), F5 TCR/CD8.1 (b, e, h, and k), or F5/ 
CD884 (c, f, i, and/) transgenic mice. The numbers inside the quadrants 
represent the percentage of cells in each population. Numbers in paren- 
theses represent the frequency ofV~x2 +cells as a percentage of CD8.2 + T 
cells (g-i) or as a percentage of CD4 + T cells (/-q). T cells (B-depleted 
lymph node cells) were analyzed with fluorescent antibodies a  described 
in Materials and Methods. 
8 
r~ 
Spleen 
F5 TCR tg FS TCR/ 
CD4-CD8.2+ 
Thymus 
F5 TCR tg F5 TCR/ 
CD884 tg 
CD4-CD8.2+ CD4-CD8.2+ 
CD884 tg 
CD4-CD8.2+ 
CD4+CD8.2- CD4+CD8.2- CD4+CD8.2- CD4+CD8.2- 
Anti-IL-2 receptor 
Figure 4. Expression of [L-2 receptor after in vitro stimulation with 
NP peptide. Splenocytes (a-d) or thymocytes (e-h) from F5 TCR or F5 
TCR/CD884 transgenic mice were incubated with NP peptide and H-2 b 
splenocytes for 48 h and analyzed for expression of CD4, endogenous 
CD8 (CD8.2), and IL-2 receptor as described inMaterials and Methods. 
IL-2 receptor levels on gated CD4+CD8.2 - and CD4-CD8.2 + popula- 
tions are shown. 
available to the F5 TCR,  we took two alternative ap- 
proaches to address this question. First, we examined ex- 
pression of  an endogenous Vow, Vet2 (Fig. 3, g-/). Whereas 
V0~2 is normally expressed on 8-15% of  mature T cells from 
normal mice (35, and data not shown), <0.5% of the CD8 + 
T cells from F5 TCR,  F5 TCR/CD8.1 ,  or F5 TCR/  
CD884 transgenic mice express Vet2 (11, and Fig. 3, g-0, 
consistent with the notion that the F5 TCR ci and [3 chains 
are expressed on these cells. In contrast, 13% of the CD4 + 
T cells from F5 TCR transgenic mice express VoL2 (Fig. 3 
j), consistent with the notion that these cells were selected 
using endogenous TCRs. It is striking that only 2% of  the 
CD4 + T cells in F5 TCR/CD884 transgenic mice express 
Va2 (Fig. 3 I), implying they, like the CD8 + T cells, ex- 
press the F5 TCR.  
As an additional confirmation that CD4 + T cells in F5 
TCR/CD884 transgenic mice express the F5 TCR,  we 
also examined the response o fT  cells from mice to nucleo- 
protein (NP) peptide as measured by IL-2 receptor induc- 
tion. Although >90% ofCD8 + T cells from both F5 TCR 
and F5 TCR/CD884 transgenic mice expression IL-2 re- 
ceptor upon stimulation with NP peptide (Fig. 4, a-f), 
only '~10% o fCD4 + T cells from F5 TCR are IL-2 recep- 
tor positive after stimulation (11, and Fig. 4, c and g). In 
contrast, >90% of CD4 § T cells from F5 TCR/CD884 
transgenic mice express IL-2 receptor in response to NP 
peptide (Fig. 4, d and h), confirming that they express the 
F5 TCR.  
Competition for Limiting "Niches" Does Not Account for the 
Reduction i  CD8 Lineage Cells in F5 TCR Transgenic Mice. 
The decrease in the mature CD8 thymocytes in F5 TCR/  
CD884 transgenic mice (Table 2) is consistent with the no- 
tion that the CD884 transgene is causing uncommitted 
thymocytes to switch fates and choose the CD4 instead of 
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the CD8 lineage. We also considered an alternative xplana- 
tion for the decrease in the mature CD8 population; that 
the large number of  mature CD4 cell thymocytes in F5 
TCR/CD884 transgenic mice are preventing CD8 lineage 
cells from being selected because of  competition between 
CD4 and CD8 lineage cells for limiting niches in the thy- 
mus (36). I f  cellular competition for limiting niches is the 
explanation for the reduction in the CD8 population, we 
could expect the proportion of  CD8 lineage cells within 
the F5 TCR/CD884 transgenic ells to increase as the pro- 
portion of  F5 TCR+CD884 + thymocytes decreases. On 
the other hand, if the CD884 transgene is diverting thy- 
mocytes from the CD8 into the CD4 lineage, we would 
expect he ratio of  mature CD4 to CD8 lineage cells to re- 
main constant as the proportion ofF5 TCR/CD884 trans- 
genic thymocytes decreases. To investigate this question, we 
constructed mixed hematopoietic stem cell chimeras from 
bone marrow of  F5 TCR and F5 TCR/CD884 transgenic 
mice. 3 wk after reconstitution, we analyzed thymocytes 
for expression of  CD4, endogenous CD8 (CD8.2), and 
transgenic CD8 (CD8.1). As shown in Table 3, there is no 
correlation between the proportion of  thymocytes that are 
derived from F5 TCR/CD884 transgenic bone marrow 
and the relative proportion of  mature CD4 and CD8 lin- 
eage cells within this population. These data indicate that 
cellular competition for limiting niches does not account 
Table 3. Ratio of Mature CD4 to CD8 Lineage Thymocytes in 
Mixed Hematopoetic Stem Cell Chimeras fiom F5 TCR/CD884 
Transgenic and F5 TCR Transgenic Mice 
Percent hymocytes derived 
from F5 TCR/CD884 
transgenic donor (CD8.1 +) 
Ratio of 
CD4 +CD8.2-/CD4-CD8.2 + 
thymocytes within the 
F5 TCR/CD884- 
derived subset (CD8.1+ 
3.4 3.6 
20 2.8 
20 12 
23 3.8 
32 6.3 
54 4.2 
81 3.7 
87 4.8 
89 3.6 
Mixed hematopoetic stem cell chimeras were generated by reconstitut- 
ing the immune systems of Rag1 mutant mice with mixtures of bone 
marrow from F5 TCR/CD884 and F5 TCR transgenic mice. After 
3-4 wk to allow reconstitution, thymocytes were analyzed by flow cy- 
tometry for expression of CD8.1 (as a marker for F5 TCR/CD884 
transgene-derived c lls), CD4, and endogenous CD8 (CD8.2). Thy- 
mocytes that were CD4- and CD8.2- (double negative) were ex- 
cluded from the analysis because their genotype could not be assessed. 
The percentage of remaining thymocytes that expressed the CD884 
transgene (CD8.1 +) is indicated. Each line represents the data from an 
individual chimera. 
for the reduction in the mature CD8 population in F5 
TCR/CD884 transgenic mice. 
The Effect of the CD884 Transgene on Selection of the anti-HY- 
TCR. We also examined the effect of  the CD884 transgene 
on selection of  the anti-HY TCR.  This TCR recognizes a 
male antigen bound to the class I molecule, H-2D b. In 
the thymus of  female anti-HY TCR transgenic mice, there 
is a substantial population of  CD4-CD8 + cells that express 
high levels of  the anti-HY TCR,  but very few anti-HY 
TCR+CD4+CD8 - cells (37, and Fig. 5 g). As previously 
observed, coexpression of a constitutive CD8.1 transgene l ads 
to an increased number of  anti-HY TCR+CD4-CD8.2  + 
thymocytes, but does not permit the development of  
CD4+CD8.2 - cells bearing the anti-HY TCR (16, and 
Fig. 5 h). In contrast, coexpression of  the hybrid CD884 
transgene l ads to the appearance of  a significant population 
of  anti-HY TCR+CD4+CD8.2  - cells (Fig. 5 t). On close 
examination, however, it is apparent hat this population 
expresses low levels of  endogenous CD8, suggesting that 
they may not be fully mature. 
I f  CD4 + thymocytes expressing the anti-HY TCR are 
fully mature, they should emigrate from the thymus and 
populate the periphery. To examine this question, we ana- 
lyzed peripheral T cells of  anti-HY TCR/CD884 mice. 
Expression of the anti-HY TCR in peripheral T cells of  fe- 
male H-2 b mice is generally low due to extensive rear- 
rangements of endogenous TCR c~ genes (37) and periph- 
eral selection for cells that do not express the anti-HY 
Total Thymus 
c~-FI-Y TCR tg c~-H-Y TCR/ c~-H-Y TCR/ 
CD8.1 tg CD884 tg 
CD8.2 
a-H-Y TCR 
a-H-Y TCR High 
,~ ]0.3 !7.7g }0 .6 /44 i~~ 
CD8.2 
Figure 5. Thymic subsets in female mice coexpressing the anti-HY 
TCR and the CD884 transgenes. Expression of CD4, CD8.2 (endoge- 
nous CD8), and anti-HY TCR (T3.70) in thymocytes from anti-HY 
TCR (a, d, andg), anti-HY TCR/CD8.1 (b, e, and h), or anti-HY TCR/ 
CD884 (c,f,, and t) transgenic mice. Thymocytes were analyzed by three- 
parameter flow cytometry using fluorescent antibodies as described in
Materials and Methods. The numbers inside the quadrants represent the 
percentage of cells in each population. Total thymocytes (a-j) or thy- 
mocytes expressing high levels of anti-HY TCR (g-J) are shown. The 
gate for discriminating anti-HY TCR high thymocytes is indicated ( -f). 
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Lymph Node T Cells 
(~-H-Y TCR/ c{-H-Y TCR/ 
(z-H-Y TCR tg CD8.1 tg CD884 tg 
CD8.2 
CD8.2 
CD4 
Figure 6. Lymph node T cells in female mice coexpressing the anti- 
HY TCR and the CD884 transgenes. Expression of CD4, CD8.2 (en- 
dogenous CD8), and anti-HY TCR in lymph node T cells from anti-HY 
TCR (a, d, andg), anti-HY TCR/CD8.1 (b, e, and h), or anti-HY TCR/ 
CD884 (c, f and 0 transgenic mice. The numbers inside the quadrants 
represent the percentage of cells in each population. Four mice of each 
genotype were analyzed and representative data re shown. T cells (B-deple- 
ted lymph node cells) were analyzed by three-parameter flow cytometry 
using fluorescent antibodies a described inMaterials and Methods. 
TC1K (38). There is, however, a distinct population of  CD8 
cells expressing high levels of  the anti-HY TCP, (37, and 
Fig. 6, a and d). Coexpression of  a constitutive CD8.1 
transgene leads to an increase in anti-HY TCR+CD8.2  + 
lymph node T cells, but does not increase the anti-HY 
TCR+CD4 + population (16, and Fig. 6, b, e, and h). In 
mice expressing both the CD884 and the anti-HY TCR 
transgene, there is a further increase in the anti-HY 
TCP,+CD8 + population (Fig. 6, c and f).  It is important to 
note that there is also a small (1%) but distinct population 
of  CD4 cells expressing high levels of  the anti-HY TCIK 
(Fig. 6 I]. Taken together, these data indicate that expres- 
sion of  the CD884 transgene permits the development of  
some anti-HY TCR + CD4 lineage cells. However, unlike 
the F5 TCR,  for which coexpression of  the CD884 trans- 
gene leads to a predominance of  CD4 cells over CD8 cells, 
coexpression of  the CD884 protein with the anti-HY 
TCP, produces predominately CD8 lineage T cells and 
only a small number of  mature CD4 lineage cells. 
Discussion 
In this paper we show that expression of  a hybrid mole- 
cule consisting of  the extracellular and transmembrane por- 
tions of  CD8 and the cytoplasmic portion of  CD4 leads to 
the development of  large numbers of  mature class I~spe- 
cific, CD4 + T cells. In contrast, expression of  a wild-type 
CD8 transgene at comparable levels allows only a small 
number of  class 1--specific, CD4 lineage cens to develop. 
These results indicate that the cytoplasmic tail of  CD4 de- 
livers an intracellular signal that favors the development of  
CD4 lineage T cells. This observation provides a molecular 
basis for differential signaling in response to class I or II 
MHC recognition during thymic development which could 
serve to direct the CD4/CD8 lineage decision. 
One feature of  our data is most compatible with instruc- 
tive models for lineage commitment. We find that in F5 
TCR/CD884 transgenic mice, the increase in CD4 lineage 
cells is accompanied by a decrease in the mature CD8 pop- 
ulation. This decrease in the mature CD8 compartment is 
seen even when the F5 TCR/CD884-bear ing thymocytes 
represent a minority of  total thymocytes, indicating that the 
effect is not due to cellular competition. Whereas an in- 
structive model predicts that mature CD4 cells might ap- 
pear at the expense of CD8 cells, i fCD884 expression "res- 
cues" already committed CD4 lineage cells, it is not obvious 
why the development of  CD8 lineage cells should be im- 
paired. Because this feature of  the data is not readily ex- 
plained by a stochastic model, we favor the explanation 
that the CD884 hybrid molecule acts at an uncommitted 
stage of T cell development to instruct cells to choose the 
CD4 lineage. 
The different abilities of  the CD884 hybrid coreceptor 
and wild-type CD8 to  generate class I-specific, CD4 lineage 
T cells focuses attention on the CD4 cytoplasmic domain. 
What feature of  these 31 amino acids favors the development 
of  CD4 lineage cells? The CD4 cytoplasmic domain inter- 
acts with the tyrosine kinase Lck, raising the possibility that 
Lck is ultimately responsible for the effects of  the CD4 cy- 
toplasmic domain on T cell development. If this is the case, 
this effect is likely to be quantitative, because the cytoplasmic 
domain of  CD8o~ also interacts with Lck, albeit more weakly 
(27-29). It is also possible that there are qualitative differ- 
ences between the CD4 and CD8 intracellular signals and 
that as yet unidentified signaling molecules are associated with 
CD4 or CD8. Experiments to identify more precisely the 
region of  the CD4 tail that is responsible for these effects are 
in progress. 
The quantitative difference in the ability of  CD4 and CD8 
to associate with and activate Lck suggests a possible expla- 
nation for the effect of  the CD4 cytoplasmic tail on T cell 
fate. Signal transduction through the TCR occurs via a series 
of  tyrosine phosphorylations and involves the sequential in- 
teraction of  at least two tyrosine kinases, Lck and ZAP-70 
(for a review see reference 39). We suggest that the quantity 
of  Lck associated with the TCR complex during MHC rec- 
ognition might impose a bias on lineage commitment, such 
that MHC engagement that produces weak Lck activation 
would be more likely to result in CD8 lineage cells, 
whereas trong Lck activation would be more likely to re- 
sult in CD4 lineage cells. Because CD8 binds Lck more 
weakly than CD4, class I MHC recognition would tend to 
produce CD8 lineage cells, whereas class II MHC recogni- 
tion would be more likely to produce CD4 lineage cells. 
Although differential recruitment of Lck by CD4 or CD8 
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would have a strong impact on lineage commitment, he 
level of Lck associated with the TCR could be affected by 
other factors as well. It has been shown that phosphoryla- 
tion of the ~ chain of the TCR by Lck and recruitment of 
ZAP-70 can occur in the absence of CD4 and CD8, im- 
plying that there are multiple pathways for activating Lck 
(for a review see reference 39). Although other means of 
recruiting Lck to the TCR complex have not yet been 
characterized, it is possible that additional factors, such as 
the extent of TCP,, cross-linking by MHC, could affect he 
level of Lck in the TCR complex and influence the CD4/  
CD8 lineage decision independently of coreceptor engage- 
meri t .  
Obviously, quantitative considerations alone cannot ex- 
plain the strict correlation between TCR specificity and 
CD4 or CD8 lineage commitment that is normally ob- 
served. However, indications that positive selection may 
require prolonged TCR engagement (40, 41), along with 
the observation that constitutive coreceptor expression can 
THYMOCY'I'ES WITH CLASS II SPECIFIC TCRs 
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S  lWCD81Ow CO8- 
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CD8+ Ick 
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.......... ~ CD41OW 
CD8+ 
THYMOCYTES WITH CLASS I SPEQFIC TCRs 
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Ick CD4+ 
CD4+ sy  CD81OW 
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CDS+ Ick weak 
~ i g n a I Ick 
CD41OW signal CD4"  
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Figure 7. A quantitative, instructive model for the CD4/CD8 hneage 
decision. This model is based on the assumption that positive selection is 
not a "single-hit" event, and that MHC engagement influences the lin- 
eage choice of an uncommitted thymocyte. The width of the arrow de- 
notes the proportion of thymocytes that take a particular pathway and the 
the darkness of  the arrow indicates the extent of  Lck activation. Accord- 
ing to this model, MHC recognition that leads to weak activation of Lck 
biases development to the CD8 lineage, whereas MHC recognition that 
leads to strong Lck activation biases toward the CD4 lineage. Most thy- 
mocytes bearing class II-specific TCRs would receive a strong Lck signal 
(due to Lck activation by CD4) and would begin to downregulate CD8. 
These tliymocytes would continue to receive a strong intraceflular signal 
through the TCR and CD4, and would therefore continue to mature. 
Most cells bearing class I-specific TCRs would receive a weaker signal 
(due to weak Lck activation by CD8) and would downregnlate CD4. A 
continued weak signal through TCP,. and CD8 would permit their final 
maturation. The requirement for continued MHC recognition after the 
downregulation of one of the coreceptors serves as a "confirmation" step 
to insure that cells that downregulate the wrong coreceptor do not ma- 
ture. Note that if cells that have begun CD8 downregnlation are not yet 
lineage colrlmitted (8), then the confirmation step could also influence the 
lineage choice of uncommitted cells. 
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sometime "rescue" cells of the wrong lineage (9-15), sug- 
gest that there is a "confirmation step" after the initial 
MHC encounter. Based on these observations, as well as 
our data, we favor the model depicted in Fig. 7. In this 
model, the initial encounter with MHC leads to a bias in 
lineage commitment such that most thymocytes expressing 
class II-specific TCRs receive a strong signal and begin to 
downregulate CD8. However, some thymocytes bearing 
class II-specific TCRs (perhaps those with weaker avidity 
for peptide/MHC on thymic epithelial cells) turn off CD4 
instead. Because CD4 would be required for continued 
class II-specific TCRs that retain expression of CD4 could 
survive, whereas those that have downregulated CD4 would 
die, Likewise, most cells expressing class I-specific TCR.s 
would receive a weaker Lck signal and would downregu- 
late CD4. Cells that continue to receive a weak signal could 
complete maturation to a CD8 lineage. Thymocytes with 
class I-specific TCRs that receive a stronger TCk  signal 
might downregulate CD8 instead of CD4, however those 
cells would not complete maturation to a CD4 hneage be- 
cause of the continued requirement for class I recognition 
throughout maturation. 
It is interesting to consider the possibility that the confir- 
mation step might also be instructive, i.e., that it may affect 
the lineage decision of an uncommitted cell. Although it is 
often assumed that CD4+CD8 l~ thymocytes are commit- 
ted to a CD4 lineage, there is litde evidence supporting this 
assumption. Indeed, intrathymic transfer of CD4+CD8 l~ 
thymocytes indicates that some of these cells can differenti- 
ate into CD8 lineage cells (8). If CD4+CD8 l~ thymocytes 
are uncommitted, then the signal that they receive upon 
MHC recognition might be instructive. A strong signal 
would lead them to become CD4 cells, whereas a weak 
signal would divert them to the CD8 lineage. 
This quantitative model may provide an explanation for 
the different effects of the CD884 transgene on two indi- 
vidual class I-specific TCR.s. If the F5 TCR is relatively ef- 
fective at generating an intracellular signal (due to the high 
avidity of the F5 TCR. for peptide/MHC or due to a high 
density of the positive-selecting li and on thymic epithelial 
cells), then the Lck associated with the CD884 protein 
might be sufficient o divert the majority of cells to the 
CD4 lineage. On the other hand, thymocytes expressing 
the anti-HY TCP,. might experience a relatively weak in- 
tracellular signal during positive selection. If that were the 
case, then increasing the activation of Lck by engaging the 
CD884 protein might not be sufficient o complete matu- 
ration to the CD4 lineage. It is interesting to note that the 
thymus ofanti-HY TCRJCD884 transgenic mice contains 
a very prominent CD4+CD8 l~ population. This may re- 
flect the fact that thymocytes expressing both the anti-HY 
TCR and CD884 transgenes receive a stronger intracellular 
signal that may be sufficient o downregulate CDS, but not 
to permit complete maturation to the CD4 lineage. 
Earlier studies (42) indicated that CD4 intracellular sig- 
nals are dispensable for the development of some CD4 lin- 
eage cells. At first glance, these results appear to contradict 
the role for the CD4 cytoplasmic tail indicated here. How- 
ever, it is possible that the CD4 cytoplasmic tail could pro- 
mote the development of  CD4 lineage cells and still not be 
essential for the development of  all CD4 cells. The CD4 
cells that develop in the absence of a CD4 cytoplasmic tail 
may bear high avidity TCRs  that would generate strong 
intracellular signals. Such cells might not require the Lck 
associated with CD4 in order to develop into CD4 lineage 
T cells. The fact that the substitution of physiological levels 
of  tail-less CD4 for endogenous CD4 restores only a frac- 
tion of  the normal numbers of  mature CD4 cells is consis- 
tent with this explanation. 
An earlier report describing a hybrid CD8/CD4 trans- 
gene (18) differs from our results in a number of  important 
respects. In the previous report, a population of  peripheral 
T cells expressing both CD4 and endogenous CD8 was ob- 
served. We see no evidence for such a population in our 
studies. Moreover, in a preliminary study, expression of  the 
previously described CD8/CD4 hybrid transgene in class II 
mutant mice did not produce an increase in the mature 
CD4 population (Jane Pames, personal communication). 
The failure to generate class I-specific CD4 cells using this 
particular hybrid coreceptor could be due to the fact that 
CD813 was not coinjected with the CD8/CD4 hybrid trans- 
gene or due to the level or timing of expression of  the 
transgene. It may also be relevant hat our CD8/CD4 hy- 
brid transgene uses the transmembrane s gment of  CDS, 
whereas the one described in the earlier study uses the 
transmembrane s gment of  CD4. 
A number of  recent studies have emphasized the stochas- 
tic nature of  the process of CD4/CD8 lineage commitment 
and the lack of  an absolute requirement for CD4 and CD8 
intracellular domains in thymic development. In spite of 
this, the critical issue of  whether intracellular signals gener- 
ated upon MHC recognition influence the fate of uncom- 
mitted thymocytes remains unresolved. The data in our pa- 
per clearly demonstrate that the CD4 intraceUular domain 
does play an important role in the CD4/CD8 lineage deci- 
sion. Moreover, our data are most compatible with the no- 
tion that CD4 intracellular signals act on uncommitted thy- 
mocytes to influence their lineage decision. 
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